Byetta

Market Update 07-20-09

-------------------------------------
Inside this week's update...
 
***** Healthcare and the state of America.
***** Bureaucracy. Need we say more?
***** The strength of our competition.
------------------------------------
 
If you've been with us for any length of time, you probably have a thorough understanding of why you should invest in commodity stocks, energy, gold, and BRACC nations. These sectors are destined to be the long-term winners.
 
But today we're going to talk about something a little different: healthcare, and what it tells us about the growing dysfunction of American society (oh yes, and about making money too)...
 
 
THE MOUNTING COST OF COMPLEXITY
 <
Read more...

Market Update 05-03-06

Dhahran الظهران

Image via Wikipedia

Volume 3, Number 18 

May 3, 2006 

Amylin's shares are off sharply from their recent highs because demand for its diabetes drug Byetta is outpacing the company's production capabilities. More specifically, if growth continues at its current month-over-month pace of 20 to 25 percent for 10 mg pens and in excess of 40 percent for 5 mg pens, the company would experience some delays in filling prescriptions sometime this summer.Read more...

Market Update 05-04-05

 Visitors attend Baghdad...

Image by Getty Images via Daylife

Weekly Update 

Amylin received the approval they were seeking for Byetta with a favorable label. In addition, the FDA informed the company that they could seek the use of the drug as a stand-alone treatment, which is a bonus they weren't expecting. Regardless of whether it's marketed as a stand-alone therapy or in conjunction with other therapies, as a first-in-class drug Byetta has the potential to be a blockbuster, generating $1 billion to $2 billion in annual sales.Read more...

Market Update 05-04-05

 business leaders

Image by squareintheteeth via Flickr

May 4, 2005 

Update


Amylin Pharmaceutical's conference call this afternoon went a long way to clarifying investors' misperceptions surrounding Byetta and the FDA's labeling of the drug. The company also reinforced the market potential of the drug. And the market potential for Byetta is big.Read more...

THE REAL REASON OIL PRICES ARE DOWN 09-02-08

For the next few weeks at least, the sun seems destined to shine on the stock market. Not only has Hurricane Gustav turned out to be far less devastating than Katrina, but the credit crisis seems to be reaching a conclusion. And if that weren't enough, oil prices have shrugged off Russia's aggression in Georgia – or perhaps they are just in a temporary state of shock and denial. Regardless, all these factors have lessened the downside risk in stock prices, for now.

In the big economic picture, one eye-catching statistic is the fact that the number of houses under construction has now fallen below the number of new home sales. This implies that today's excess inventory could start to shrink, improving the supply/demand situation, and supporting house prices.

Of course, we are a long way from the time when home prices start rising again. There is a lot of inventory to be worked through first. But the key in economics and investment is not where you are, but where you are going. It doesn't matter how much a stock is worth today. What makes it a good or bad investment is whether its price is heading higher or lower. Similarly, the health of the economy is determined by the direction various statistics (GDP, CPI, etc.) are moving, not what level they are at now. Home prices have been the weakest part of the economy recently, so an improved trend in home construction is welcome news.Read more...

HOW OIL AND POLITICS MIX 04-21-08

The market has us worried these days. We'd be dishonest not to admit that. Nonetheless, when we sit back and look at the economic data, we find it much easier to make a bullish case than a bearish one.

We've been straining our eyes, peering over the horizon, looking for signs of a real recession, but none are to be found. We can accept that the U.S. economy might get a recession in name only – a quarter or two of very mild slowing growth – but nothing worse than that.

There's just no hard evidence to support a serious downturn. And any evidence we can find is uniformly softer than a roll of Charmin – stuff like survey data, unemployment stats, and weakening consumer confidence (no doubt brought on by scary but exaggerated newspaper headlines).

Fortunately, as insecure as the average consumer claims to be, he hasn't cut back on spending in a meaningful way.

We're not just referring to recent retail sales, which is one of those soft figures based on surveys. Hard data from Wal-Mart, the biggest retailer of them all, strongly suggest that money is still moving through the tills at a brisk pace. Wal-Mart stock has racked up an 18% gain so far this year. And when the market cap of a $222 billion-dollar company rises 18%, that's real money – nearly $40 billion of it, in fact. Not something that would happen if retail sales were plummeting.Read more...

WHY THE BEST DRUGS ARE BAD FOR BUSINESS 07-02-07

Official, core inflation continues to look rosy and supportive of stocks. Last week we asked the question, “When will the Fed acknowledge that non-core items, food and energy, are definite contributors to inflation?” The answer matters, because such an acknowledgement could be the trigger that sends the market into a trading range.

Right now, the Fed is getting off easy because they only pay heed to core inflation. And core inflation has been well behaved. However, if you add in food and energy, total inflation is running at around 5.5%, which is disturbingly high and certainly takes all the appeal out of buying bonds.

For that reason, we expect the small current rally in bonds will be over soon and that bond prices will be heading lower. We are not chasing this bond rally, and we will not be buying bonds anytime soon.

Instead, at the risk of sounding contrarian, we expect to see a big move upwards in gold prices in the coming months. Summer is usually the weakest period for gold, the time when bottoms are made. So we aren’t concerned about the metal’s limp performance lately. Keep in mind that when gold does make its big moves they tend to be dramatic, giving handsome rewards to those who bought low.Read more...

GREENSPAN’S CONUNDRUM 06-13-05

Last week stocks made another slight gain. Our guess is that so long as oil stays in the $50s, the rally may continue. But when oil makes another big move up, it will be time to reassess.

GREENSPAN’S CONUNDRUM

I talked a little last week about the conundrum that’s been perplexing Alan Greenspan, our beloved Federal Reserve Chairman since February. He can’t quite figure out why long-term bond interest rates have fallen so low, when the Fed has been aggressively raising short-term rates by 0.25% at every meeting.

Normally long-term rates rise along with short-term rates. Not that they have to – since long-term rates are set by the market, not by the Federal Reserve. But they always have before, which is why Greenspan last week commented, “Something unusual is clearly at play here.”

Even more interesting, long-term rates are down in other nations as well – from Europe to Japan. And even corporate junk-bond rates have fallen.

We see this historic development as an outlier of unimaginable proportions. It implies the Fed has lost its magic wand. It can no longer control the economy, nor be relied on to stem the growing tide of inflation.Read more...

Weekly Update 05-31-05

   Pupils play dur...

Image by Getty Images via Daylife

Last week I talked about two popular beliefs, one touted by Wall Street, the other by environmentalists. One of these beliefs we know is a delusion. The other we’re still undecided on. But from them, we draw two conclusions that could help you make a lot of money over the next few years:

1) Think for yourself, and never blindly trust authority.

2) Invest in oil and alternative energies.

Today, as I promised, I’m going to tell you about another popular delusion. One that you may also find profitable …

“OVERWEIGHT PEOPLE LIVE LONGER” (TELL THAT TO YOUR SPOUSE!)

Another area in which society may be deluding itself concerns obesity. Recently, the Journal of the American Medical Association (one of the most prestigious medical publications) printed a study suggesting that, contrary to popular belief, it may be healthier to be overweight than thin.  Read more...

Weekly Update 05-09-05

Wall Street

Image by Matt, Marie, Luke and Finn via Flickr

 

Last week was good for stocks, with the Dow and the S&P making positive gains that broke them out of a short-term downtrend. Unfortunately, the weakness we hoped for in oil took a breather too, with oil prices ending the week back above $50.

Nonetheless, we think stocks will continue to climb for the next little while at least. Right now, several of our market indicators are at extreme values. The near-term picture painted by these “outliers” is very bullish, with very little downside risk. That doesn’t contradict our long-term expectation that rising inflation will affect the markets adversely – but for the next little while, things look good. Here’re the details …

Last week, I mentioned that the extremely low specialist shorting figure is a bullish omen. It was no fluke. This week’s number was just as unusually low, coming in once again at less than 2% of NYSE value. That’s less than half the historical average. In fact, in 30 years of following the markets, this is the first time I’ve seen the figure this low for two consecutive weeks.Read more...